GlassScriptPhysician profile
Thomas S Walter
NPI 1881681492
$1,250.99
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.88 · 2021: $281 · 2022: $594 · 2023: $168 · 2024: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.96 | 2021-2023 | Orilissa, Lo Loestrin Fe |
| Myovant Sciences INC. | $177.81 | 2021-2022 | |
| Pfizer INC. | $162.56 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $160.39 | 2021-2024 | |
| Astellas Pharma US INC | $80.68 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $49.72 | 2023-2024 | Thinprep 2000 Processor, Aptima |
| Exeltis, USA INC. | $44.32 | 2021-2023 | Tyblume |
| Therapeuticsmd, INC. | $40.83 | 2019-2022 | |
| Evofem Biosciences, INC. | $40.53 | 2022 | |
| Sumitomo Pharma America, INC. | $28.55 | 2023 | Myfembree |
| Organon LLC | $25.25 | 2022 | |
| Coopersurgical, INC. | $21.09 | 2024 | Paragard T 380a |
| Ascend Therapeutics US, LLC | $19.36 | 2022 | |
| Merck Sharp & Dohme LLC | $18.99 | 2024 | Gardasil 9, Gardasil |
| Allergan, INC. | $18.26 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.50 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.19 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.